DDB Worldwide Named Cannes Lions 2025 Network of the Year for the Second Time in Two Years
CANNES, France, June 20, 2025 /CNW/ -- DDB Worldwide, part of Omnicom, has once again claimed the prestigious title of Network of the Year at the 2025 Cannes Lions International Festival of Creativity. This marks the second time the network has secured the honor, following its historic first win in 2023. In a record-breaking year, DDB surpassed its 2023 award tally with a total of 112 Lions, further cementing its place at the forefront of the global creative industry.
DDB's continued rise comes just one year into the leadership of Global CEO Alex Lubar and President & Global Chief Creative Officer, Chaka Sobhani. Since taking the reins, the duo has steered the network into a new era; one defined by tighter integration, emotionally-led creativity, and a sharpened focus on work that delivers both cultural impact and real business results.
Chaka Sobhani commented: "I literally don't have the words. This means the absolute world to us. I couldn't be prouder of our DDB network and the passion, commitment, and love that has gone behind us getting here. A huge thank you also to our amazing clients for their trust and partnership - we wouldn't be here without you and I hope we've made you proud. Hopefully, this is the start of much more to come from DDB - and on a personal note, I can only say it's been the most incredible first year!"
"2023 was a landmark year for DDB, but we saw it as the beginning," said Alex Lubar. "The momentum you're seeing now is the result of a global network aligned around a simple belief: creativity is the most powerful force in business. I'm incredibly proud of our exceptional teams and client partners on this collective effort."
2025 Cannes Lions highlights:
Regional Network of the Year - Latin America
Regional Network of the Year - Pacific
Classic Track Agency of the Year - Africa Creative DDB
Good Track Agency of the Year - Africa Creative DDB
Experience Track Agency of the Year - DM9
Africa Creative DDB is the 1st ranked agency in Brazil, 2nd in Agency of the Year
The first time DDB won four Grands Prix across different brands since 2016, including:
Audio & Radio: "One Second Ads" (Budweiser, Africa Creative DDB)
Music: "Tracking Bad Bunny" (Rimas Entertainment, DDB Latina Puerto Rico)
Creative Data: "Efficient Way to Pay" (Consul, DM9)
Sustainable Development Goals: "The Amazon Greenventory" (Natura, Africa Creative DDB)
20 total Gold Lions
37 total Silver Lions
51 total Bronze Lions
320 total shortlists
First Gold Cannes Lion in Finland for Nordea, Parental Leave Mortgage
First Grand Prix for DDB Latina Puerto Rico, and Puerto Rico's second in history
First Gold for DDB Warsaw for McDonald's Winter Takes on Color in Brand Experience & Activation
Most Lions and Grands Prix won by DDB Latina ever, with 78 trophies vs their previous record of 44
Most awarded network in Brand Experience & Activation with 20 trophies
Most awards on behalf of McDonald's than any other agency network
This creative surge has been powered by the DDB Global Creative Council, Bullseye, which is led by Global Chief Creative Operations Officer, Susie Walker, and continues to push boundaries across regions. This year, the program has been expanded to include rising creative talent, who have actively shaped DDB's award-winning creative work.
DDB's rise has also been fueled by the growing influence of some of its most dynamic agencies, including DDB Paris, Africa Creative DDB, alma, DM9, and NORD DDB, whose bold, culturally resonant work continues to redefine the standard of global creative excellence.
As creativity becomes an increasingly vital business differentiator, DDB's Cannes success proves its belief that emotional storytelling not only moves people, it moves markets. This year's winning campaigns have not only earned accolades but delivered measurable growth for clients across categories.
ABOUT DDB WORLDWIDE
DDB (www.ddb.com) is The Emotional Advantage Agency.
We believe when people feel, they act—and when they act, brands grow. That's the emotional advantage. We use it to deliver intimacy at scale, unlock brand growth, and craft ideas that move people, business, and culture forward.
As one of the world's leading advertising and marketing networks, DDB blends creative excellence with strategic effectiveness to drive measurable results. With 140 offices in 60+ countries, we partner with iconic brands like MARS, McDonald's, Molson Coors, Volkswagen, Amazon, Unilever, JetBlue, Adidas, PlayStation, and the U.S. Army.
Our impact is proven: we were named the #1 Most Awarded Agency Network in the 2024 Effie Global Best of the Best, Global Network of the Year by Cannes Lions (2023 and 2025), and D&AD Network of the Year for three consecutive years (2021–2023). We've also ranked as a Top 3 Global Network on WARC for 13 of the last 16 years.
Founded in 1949, DDB is part of Omnicom (NYSE: OMC).
Media ContactPress@ddb.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ddb-worldwide-named-cannes-lions-2025-network-of-the-year-for-the-second-time-in-two-years-302487545.html
SOURCE DDB Worldwide
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2025/20/c3934.html
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S.
CARAC (fluorouracil cream), 0.5% Extrovis AGBahnhof Park 46340, Baar, Switzerland Media Relations ContactMadhu Press Release Extrovis AG and Dr. Reddy's announce the launch of the authorized generic of CARAC (fluorouracil cream), 0.5% in the U.S. Baar, Switzerland; August 14, 2025 Extrovis AG, a global pharmaceutical company focused on research-driven innovation, and Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as "Dr. Reddy's"), today announced the launch of Fluorouracil Cream, 0.5%, an authorized generic and therapeutic equivalent of Carac® (fluorouracil cream) 0.5%, in the US market, approved by the U.S. Food and Drug Administration (USFDA). Manufactured in Texas at one of Extrovis' facilities, Dr. Reddy's Fluorouracil Cream, 0.5%, is indicated for the topical treatment of multiple actinic or solar keratoses of the face and anterior scalp. 'This product generic launch marks a key milestone in our commitment to increasing patient access and long-term value creation for the U.S. healthcare system. Our partnership with Dr. Reddy's helps ensure that patients and healthcare providers in the United States have continued access to a high-quality and cost-effective product,' said Hans R. Kamma Co-CEO and Chief Strategy Officer of Extrovis AG. 'Dr. Reddy's brings deep expertise in commercialization and distribution within the U.S. market,' added Raghavendra Rao PV, Chief Financial Officer of Extrovis AG. 'This collaboration is aligned with our mission to strengthen pharmaceutical supply chains and serve public health needs responsibly.' The partnership reinforces Extrovis' strategy to extend the reach of its therapeutics while advancing long-term affordability and sustainability in healthcare. Dr. Reddy's Fluorouracil Cream, 0.5%, is supplied in a 30-gram tube for topical use only. Please click here to see the full prescribing information. Carac® is a trademark of Extrovis AG ……………………………………………………………………………………..…………………………………………………………………………………………………………………… About Dr. Reddy'sAbout Dr. Reddy's: Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of 'Good Health Can't Wait', we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: About Extrovis AGExtrovis AG is a Switzerland-based global biopharmaceutical company committed to developing and commercializing high-quality therapies for unmet and under-addressed medical needs. With R&D and manufacturing operations in the USA, Italy, Hungary, and India, Extrovis delivers innovative, differentiated products across key therapeutic areas. Backed by strong R&D capabilities, regulatory expertise, and a robust global quality framework, the company advances its mission to improve patient outcomes and expand access to essential health care products worldwide. For more information, log on to: ……………………………………………………………………………………………………………………………………………………… Disclaimer: This press release may include statements of future expectations and other forward-looking statements that are based on the management's current views and assumptions and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the words "may", "will", "should", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "potential", or "continue" and similar expressions identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency exchange rates, interest rates, persistency levels and frequency / severity of insured loss events, (ii) mortality and morbidity levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization, including related integration issues, and (vi) the susceptibility of our industry and the markets addressed by our, and our customers', products and services to economic downturns as a result of natural disasters, epidemics, pandemics or other widespread illness, including coronavirus (or COVID-19). The company assumes no obligation to update any information contained herein. Attachment CARAC (fluorouracil cream), 0.5%Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
Evelyn Partners targets NatWest and RBC as potential buyers
Evelyn Partners is preparing for a sale that could see the company valued at approximately £2.5bn, reported Financial Times, citing sources. The company's private equity owners, Permira and Warburg Pincus, have appointed Evercore to facilitate the sale process, which is expected to commence soon. Evelyn Partners aims to capitalise on the increasing appetite among banks to augment their financial advisory services, the report said. Potential bidders for the wealth manager include banking institutions such as NatWest and Royal Bank of Canada, as well as other private equity firms and US wealth managers with an interest in the UK market, such as Raymond James. The sale initiative comes after NatWest's transition back to private ownership, which was completed in May this year. The bank previously engaged in exploratory talks with Evelyn Partners and is said to be considering a bid once the company is officially on the market. NatWest's strategy has been to grow its wealth management business, which features the high-profile Coutts bank. Royal Bank of Canada, which has previously expressed its intention to expand its wealth management footprint in the UK, is another potential suitor. Evelyn Partners' CEO, Paul Geddes, has past ties with Royal Bank of Scotland, having led its retail banking division, which included the NatWest brand. The sale would represent an exit for Permira from its investment in Evelyn Partners, which began with the merger of Bestinvest and Tilney in 2014. Warburg Pincus later contributed to the merger of Tilney and Smith & Williamson in 2020, after which the company was rebranded as Evelyn Partners. Last year, the group's focus shifted exclusively to wealth management following the sale of its professional services arm to Apax. Both NatWest and Royal Bank of Canada have refrained from commenting on what they describe as "market speculation." Similarly, Evelyn Partners, Permira, and Warburg Pincus have not provided any official statements regarding the sale. Raymond James has not responded to inquiries for comment. "Evelyn Partners targets NatWest and RBC as potential buyers – report " was originally created and published by Private Banker International, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
%3Amax_bytes(150000)%3Astrip_icc()%2FTAL-tower-bridge-london-england-EUROFLIGHTS0825-8bfcac6ea9af470dbf4bfe9abef5b0e9.jpg&w=3840&q=100)
Travel + Leisure
14 minutes ago
- Travel + Leisure
You Can Fly to Europe for Under $130 This Fall—Destinations Include London, Paris, and Rome
Low-cost airline Norse Atlantic recently published discounted fares for fall travel from $129. The airline offers direct service from New York to popular European travel destinations, including London, Paris, and Rome. The discounted tickets overlap with the travel 'shoulder season" when airlines and hotels provide lower prices to entice travelers. The summer travel season may be winding down, but fall airfare savings are just taking off. Travelers looking to explore Europe are in luck as airlines are deeply discounting overseas flights. In fact, passengers can book for less than $130 throughout September, October, and November. Low-cost carrier Norse Atlantic Airways recently published discounted fares as low as $129 when flying from New York's John F. Kennedy International Airport (JFK) to London Gatwick Airport (LGW), and starting at $149 when flying from New York to Rome's Leonardo da Vinci/Fiumicino Airport (FCO). The airline, which based in Arendal, Norway, also has one-way direct flights from New York to Berlin Brandenburg Airport (BER) and Oslo Airport (OSL) for under $140. Travel + Leisure spotted a variety of additional discounted fares including: Los Angeles International Airport (LAX) to Athens International Airport (ATH) from $158 throughout September LAX to Paris Charles de Gaulle Airport (CDG) from $132 on Oct. 5 New York to Athens from $149 on Oct. 7 New York to London from $129 on Oct. 15 Orlando International Airport (MCO) to London from $149 on Oct. 12 The low fares come on the heels of Norse's decision to launch new service between Bangkok and London. Those flights are set to take off in October. The discounted prices are for seats in Norse's Economy Light cabin, which includes a personal item and a carry-on bag weighing up to 22 pounds. Travelers should be advised the tickets are restrictive and can only be changed for a hefty fee. In addition, travelers can book their tickets in the carrier's Economy Classic cabin, which includes a meal service and a checked bag; or in the Premium cabin, which includes complimentary soft drinks and alcoholic drinks, as well as priority boarding with extra legroom, and amenity kits. The Premium Cabin doesn't offer lie-flat seats, but does include an "excellent recline" with a 43-inch seat pitch and is designed to be wider, according to the airline. Norse Atlantic was founded in 2021 and now operates a fleet of Boeing 787 Dreamliner aircraft. These deals overlap with "shoulder season", a travel period that falls between the busy summer and the end-of-year holidays. Traditionally, travelers can find the lowest prices of the year on flights, hotels, and rental cars thanks to lower demand. This year, travelers can get great deals to popular European destinations like Lisbon, Nice, Venice, Munich, and more.
